Premium
Ziprasidone‐related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge
Author(s) -
Gray Nicola S.
Publication year - 2004
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.578
Subject(s) - ziprasidone , neuroleptic malignant syndrome , parkinson's disease , medicine , disease , antipsychotic , psychiatry , pediatrics , schizophrenia (object oriented programming)
A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed. Copyright © 2004 John Wiley & Sons, Ltd.